Prior to diagnosis, the patient was treated for heart failure with preserved ejection fraction with diuretics, sodium-glucose cotransporter-2 inhibitors, and angiotensin receptor-neprilysin inhibitors. The gene discussed is SLC5A2; the disease is heart failure.